{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Bushnell C"],"funding":["NINDS NIH HHS"],"pagination":["241-50"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3074540"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(3)"],"pubmed_abstract":["Although women have a lower incidence of stroke than men in most age groups, women have an overall increased lifetime risk of stroke. Women also have unique risk factors for stroke, including the menopausal transition, the existence of debilitating vasomotor symptoms for some women, and the issues related to hormonal treatment for those symptoms. Although the initial studies of hormone therapy (HT) use in postmenopausal women suggested significant protection against heart disease, there was no obvious protection against stroke. Randomized trials of HT for secondary prevention showed a lack of benefit for both heart disease and stroke, and the suggestion of some early risk after initiation. However, the Women's Health Initiative (WHI), a primary prevention study of the impact of HT on women"],"journal":["Current treatment options in cardiovascular medicine"],"pubmed_title":["Hormone therapy and stroke: is it all about timing?"],"pmcid":["PMC3074540"],"funding_grant_id":["K02 NS058760","K02 NS058760-02"],"pubmed_authors":["Bushnell C"],"additional_accession":[]},"is_claimable":false,"name":"Hormone therapy and stroke: is it all about timing?","description":"Although women have a lower incidence of stroke than men in most age groups, women have an overall increased lifetime risk of stroke. Women also have unique risk factors for stroke, including the menopausal transition, the existence of debilitating vasomotor symptoms for some women, and the issues related to hormonal treatment for those symptoms. Although the initial studies of hormone therapy (HT) use in postmenopausal women suggested significant protection against heart disease, there was no obvious protection against stroke. Randomized trials of HT for secondary prevention showed a lack of benefit for both heart disease and stroke, and the suggestion of some early risk after initiation. However, the Women's Health Initiative (WHI), a primary prevention study of the impact of HT on women","dates":{"release":"2009-01-01T00:00:00Z","publication":"2009 Jun","modification":"2025-04-05T15:40:43.421Z","creation":"2019-03-27T00:40:34Z"},"accession":"S-EPMC3074540","cross_references":{"pubmed":["19433019"],"doi":["10.1007/s11936-009-0025-5"]}}